Loading...
Opportunities to Improve Symptom Control with Somatostatin Congeners in GEP‐NETs: A Review of Key Issues
Octreotide acetate (octreotide) is the most prescribed and most studied somatostatin congener, or analog, for gastroenteropancreatic neuroendocrine tumors (GEP‐NETs) and carcinoid syndrome, the latter of which may be characterized by debilitating diarrhea and flushing. Approved in the U.S. more than...
Saved in:
| Published in: | Oncologist |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley & Sons, Inc.
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8265352/ https://ncbi.nlm.nih.gov/pubmed/34097784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13847 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|